Home › Immunoblastic Lymphadenopathy › Georgia › Atlanta
Immunoblastic Lymphadenopathy clinical trials in Atlanta, GA
3 studies for Immunoblastic Lymphadenopathy are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- Emory University, Atlanta
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
RecruitingPhase 2
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- and 1 more
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Emory University (Data Collection Only), Atlanta
Immunoblastic Lymphadenopathy trials in other cities
- New York City, NY5 studies
- Durham, NC4 studies
- Houston, TX4 studies
- Miami, FL4 studies
- Chicago, IL4 studies
- New Haven, CT3 studies
- Columbus, OH3 studies
- Boston, MA3 studies
- Edison, NJ3 studies
- St. Louis, MO3 studies
- Rochester, MN3 studies
- Baldwin Park, CA3 studies
Other studies in Atlanta
- Cancer (all types)50 studies
- Non-Small Cell Lung Cancer46 studies
- Multiple Myeloma41 studies
- Breast Cancer41 studies
- Prostate Cancer32 studies
- Lung Cancer29 studies
- Colorectal Cancer29 studies
- Acute Myeloid Leukemia29 studies
- Ovarian Cancer28 studies
- Metastatic Cancer27 studies
- Obesity25 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.